ArticleCell death & disease2025

Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.

Ece Cakiroglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.